search icon
search icon
Flag Arrow Down
Română
Română
Magyar
Magyar
English
English
Français
Français
Deutsch
Deutsch
Italiano
Italiano
Español
Español
Русский
Русский
日本語
日本語
中国人
中国人

Change Language

arrow down
  • Română
    Română
  • Magyar
    Magyar
  • English
    English
  • Français
    Français
  • Deutsch
    Deutsch
  • Italiano
    Italiano
  • Español
    Español
  • Русский
    Русский
  • 日本語
    日本語
  • 中国人
    中国人
Sections
  • News
  • Exclusive
  • INSCOP Surveys
  • Podcast
  • EU
  • Diaspora
  • Republic of Moldova
  • Politics
  • Economy
  • Current Affairs
  • International
  • Sport
  • Health
  • Education
  • IT&C knowledge
  • Arts & Lifestyle
  • Opinions
  • Elections 2025
  • Environment
About Us
Contact
Privacy policy
Terms and conditions
Quickly scroll through news digests and see how they are covered in different publications!
  • News
  • Exclusive
    • INSCOP Surveys
    • Podcast
    • EU
    • Diaspora
    • Republic of Moldova
    • Politics
    • Economy
    • Current Affairs
    • International
    • Sport
    • Health
    • Education
    • IT&C knowledge
    • Arts & Lifestyle
    • Opinions
    • Elections 2025
    • Environment
134 new news items in the last 24 hours
  1. Home
  2. Health

Teplizumab, a new drug, could delay the need for insulin for patients with type 1 diabetes by up to 3 years.

Călin Nicolescu
whatsapp
facebook
linkedin
x
copy-link copy-link
8 July 2025, 08:54
main event image
Health
Foto Pixabay
google-preference

Always see our news on Google

Teplizumab, a drug already approved in the US, is being tested in the UK to slow the progression of type 1 diabetes by training the immune system to protect pancreatic cells. Hannah Robinson, the first British adult to receive the treatment, hopes it will delay the need for insulin. Experts believe the treatment represents a major change in diabetes management, with the potential to alter the immune process and help high-risk people avoid insulin therapy.

Sources

sursa imagine
Stirile ProTV
Un medicament "revoluţionar" ar putea încetini evoluţia diabetului de tip 1. Poate întârzia nevoia de insulină cu 3 ani
sursa imagine
BBC
Devon mother treated with game-changing diabetes drug
sursa imagine
independent.co.uk
Mother of two becomes the first UK patient to receive ‘groundbreaking’ new diabetes drug
sursa imagine
Hot News
Un medicament „revoluționar”, o nouă speranță pentru diabetul de tip 1. Ce așteptări au medicii

Latest News

21:13

The ANI law was rejected in the Senate. Romania risks losing 770 million euros from the PNRR.

21:10

EPPO requests for the second time the lifting of the immunity of a Polish deputy in an investigation regarding European funds

21:03

Adidas stated that the appearance of the pink football boot on the fields of the 2026 World Cup was a coincidence, not a marketing strategy.

20:49

Member of the European Parliament Diana Iovanovici-Șoșoacă announced that she is feeling well after the road accident in which she was involved, thanking the doctors and supporters for their support.

20:35

The Senate has adopted the Territorial Planning, Urbanism and Constructions Code, which will digitalize the approval of constructions and reduce bureaucracy.

See more news

NEWS ON THE SAME TOPICS

event image
EU
A project funded by the European Union is testing 100,000 children for the early detection of type 1 diabetes.
event image
Health
An experimental injection against cancer completely eliminated tumors in patients who did not respond to chemotherapy or immunotherapy.
event image
International
The European Medicines Agency has recommended the approval of the Wegovy tablet, a weight loss medication from Novo Nordisk.
event image
Health
Cats could benefit from weight loss medications. The first tests are already underway.
event image
Health
WHO begins clinical study for an antiviral drug against Ebola
event image
Health
France will start partial reimbursement of treatments for obesity from June, thus becoming the first state in the EU to subsidize these medications.
app preview
Personalized news feed, AI-powered search, and notifications in a more interactive experience.
app preview app preview
diabetes medically Teplizumab

Informat Diaspora

main event image
Diaspora
9 hours ago

61% of Romanians working abroad have invested in Romania, but do not intend to return.

Sources
imagine sursa
imagine sursa
imagine sursa

Editor’s Recommendations

main event image
Exclusive
8 hours ago
Original Content

EXCLUSIVE The ranking of themes in domestic politics in trends, in the last week

main event image
Opinions
9 hours ago

Andrei Pleșu: The Political Class. Thesaurus of Synonyms

app preview
Personalized news feed, AI-powered search, and notifications in a more interactive experience.
app preview
app store badge google play badge
  • News
  • Exclusive
  • INSCOP Surveys
  • Podcast
  • EU
  • Diaspora
  • Republic of Moldova
  • Politics
  • Economy
  • Current Affairs
  • International
  • Sport
  • Health
  • Education
  • IT&C knowledge
  • Arts & Lifestyle
  • Opinions
  • Elections 2025
  • Environment
  • About Us
  • Contact
Privacy policy
Cookies Policy
Terms and conditions
Open source licenses
All rights reserved Strategic Media Team SRL

Technology in partnership with

anpc-sal anpc-sol